Background: Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective: This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Experiential understanding of remifentanil-assisted labor from the perspectives of mothers
Timeframe: Interviews conducted within 4-10 days postpartum
Experiential understanding of remifentanil-assisted labor from the perspectives of midwives
Timeframe: Time Frame: Interviews conducted within 4-10 days postpartum